Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2018BMJOpen Access

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

XSXian ShenMinistry of EducationBZBin ZhaoMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shen et al. (2018) studied this question.

synapsesocial.com/papers/69d71c3f8a0e2c5879bef1d6https://doi.org/10.1136/bmj.k3529
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Operating Characteristics of a Rank Correlation Test for Publication Bias1994 · 17,339 citations
  2. 2Measuring inconsistency in meta-analyses2003 · 64,290 citations
  3. 3Cancer immunotherapy using checkpoint blockade2018 · 6,999 citations
  4. 4Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer2017 · 406 citations
  5. 5Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma2017 · 3,467 citations